You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Drug Price Trends for NDC 23155-0794


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 23155-0794

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
DOXEPIN HCL 10MG CAP AvKare, LLC 23155-0794-01 100 16.81 0.16810 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

23155-0794 Market Analysis and Financial Projection

Market Analysis and Price Projections for Furosemide (NDC: 23155-0794)

Introduction

Furosemide, a potent diuretic, is widely used in the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and a nephrotic syndrome. Here, we will delve into the market analysis and price projections for Furosemide, specifically focusing on the NDC code 23155-0794.

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is undergoing significant transformations driven by digital innovation, scientific advancements, and changing market dynamics. Key trends include:

  • Digital Transformation and Innovation: The integration of technologies such as gen AI and increased use of data is expected to boost operational efficiencies and drive breakthrough innovations in the life sciences industry[3].
  • Pricing and Access: Pricing and access to drugs remain significant issues, with nearly half of C-suite executives expecting these factors to impact their strategies in 2025[3].
  • Generic and Biosimilar Competition: The rise of generic drugs and biosimilars is a top trend, with 37% of respondents viewing this as a major concern due to the patent cliff and loss of exclusivity for high-revenue products[3].

Market Outlook for Diuretics

Diuretics, including Furosemide, are part of a broader therapeutic class that is not typically highlighted as a growth area in the same way as newer therapies like GLP-1 drugs for obesity or oncology treatments. However, diuretics remain essential in the management of various cardiovascular and renal conditions.

  • Stable Demand: The demand for diuretics like Furosemide is relatively stable due to their established role in clinical practice. This stability can be attributed to the ongoing need for effective management of conditions such as heart failure and nephrotic syndrome.
  • Generic Market: Furosemide is a generic drug, which means it faces competition from multiple manufacturers. This competition often leads to pricing pressures and can result in lower profit margins for individual manufacturers[3].

Price Projections

Given the generic nature of Furosemide, price projections are influenced by several factors:

  • Competition: The presence of multiple generic versions of Furosemide leads to competitive pricing. Prices tend to be lower compared to branded drugs and can fluctuate based on market competition[2].
  • Regulatory Environment: Changes in regulatory policies, such as those related to pricing and reimbursement, can impact the pricing strategy for generic drugs. For instance, the Inflation Reduction Act in the U.S. could influence pricing dynamics[4].
  • Manufacturing Costs: The cost of production, including raw materials and manufacturing processes, can also affect the pricing of Furosemide.

Current Pricing

As of the latest available data, the pricing for Furosemide can vary based on the formulation and packaging. For example:

  • Injection Solutions: Furosemide injection solutions, such as those with NDC codes 23155-473-32 or 23155-473-33, are priced based on their volume and packaging. These prices are generally lower than those of branded drugs but can vary depending on the supplier and market conditions[1].

Future Pricing Trends

Looking ahead, several factors will influence the pricing of Furosemide:

  • Increased Competition: The continued rise of generic and biosimilar drugs will likely maintain downward pressure on prices.
  • Regulatory Changes: Any changes in regulatory policies, especially those related to pricing and reimbursement, could impact the pricing strategy for Furosemide.
  • Market Demand: While the demand for diuretics is stable, any shifts in clinical practices or the introduction of new therapies could influence pricing.

Key Takeaways

  • Stable Demand: Furosemide will continue to be in demand due to its established clinical use.
  • Competitive Pricing: The generic nature of Furosemide means prices will remain competitive and potentially lower.
  • Regulatory Impact: Changes in regulatory policies can affect pricing dynamics.
  • Manufacturing Costs: Production costs will influence the final pricing of the drug.

FAQs

Q: What are the primary uses of Furosemide? A: Furosemide is primarily used to treat edema associated with congestive heart failure, cirrhosis of the liver, and nephrotic syndrome.

Q: How does the generic status of Furosemide affect its pricing? A: The generic status of Furosemide leads to competitive pricing among multiple manufacturers, resulting in generally lower prices compared to branded drugs.

Q: What regulatory factors could impact the pricing of Furosemide? A: Regulatory changes, such as those related to pricing and reimbursement policies (e.g., the Inflation Reduction Act), can influence the pricing strategy for Furosemide.

Q: How does the market outlook for diuretics compare to other therapeutic areas? A: The market outlook for diuretics is relatively stable but not as growth-oriented as areas like oncology or obesity treatments with newer therapies like GLP-1 drugs.

Q: What are the potential future trends in the pricing of Furosemide? A: Future trends include continued competitive pricing due to generic competition, potential impacts from regulatory changes, and stable demand driven by clinical needs.

Sources

  1. DailyMed: Furosemide injection, solution - DailyMed.
  2. Missouri Specialty MAC: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023.
  3. Deloitte Insights: 2025 life sciences outlook.
  4. Evaluate: Evaluate Releases 2030 Forecasts for Global Pharmaceutical Market.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.